Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MEASLES VACCINE INDUSTRY
2.1 Summary about Measles Vaccine Industry
2.2 Measles Vaccine Market Trends
2.2.1 Measles Vaccine Production & Consumption Trends
2.2.2 Measles Vaccine Demand Structure Trends
2.3 Measles Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
4.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Children
4.3.2 Adults
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
5.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Children
5.3.2 Adults
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
6.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Children
6.3.2 Adults
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
7.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Children
7.3.2 Adults
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
8.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Children
8.3.2 Adults
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
9.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Children
9.3.2 Adults
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GSK
10.1.2 Sanofi-Pasteur
10.1.3 Merck
10.1.4 Novartis
10.1.5 Pfizer
10.1.6 Serum Institute of India
10.1.7 China National Biotech Group
10.1.8 Bavarian Nordic
10.1.9 Emergent Biosolutions
10.1.10 Medimmune
10.1.11 Johnson & Johnson
10.1.12 CSL Limited
10.2 Measles Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 GSK
10.2.2 Sanofi-Pasteur
10.2.3 Merck
10.2.4 Novartis
10.2.5 Pfizer
10.2.6 Serum Institute of India
10.2.7 China National Biotech Group
10.2.8 Bavarian Nordic
10.2.9 Emergent Biosolutions
10.2.10 Medimmune
10.2.11 Johnson & Johnson
10.2.12 CSL Limited
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Measles Vaccine Product Type Overview
Table Measles Vaccine Product Type Market Share List
Table Measles Vaccine Product Type of Major Players
Table Brief Introduction of GSK
Table Brief Introduction of Sanofi-Pasteur
Table Brief Introduction of Merck
Table Brief Introduction of Novartis
Table Brief Introduction of Pfizer
Table Brief Introduction of Serum Institute of India
Table Brief Introduction of China National Biotech Group
Table Brief Introduction of Bavarian Nordic
Table Brief Introduction of Emergent Biosolutions
Table Brief Introduction of Medimmune
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of CSL Limited
Table Products & Services of GSK
Table Products & Services of Sanofi-Pasteur
Table Products & Services of Merck
Table Products & Services of Novartis
Table Products & Services of Pfizer
Table Products & Services of Serum Institute of India
Table Products & Services of China National Biotech Group
Table Products & Services of Bavarian Nordic
Table Products & Services of Emergent Biosolutions
Table Products & Services of Medimmune
Table Products & Services of Johnson & Johnson
Table Products & Services of CSL Limited
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Measles Vaccine Market Forecast (Million USD) by Region 2021f-2026f
Table Global Measles Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Measles Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Measles Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f